ASX LISTING RULES
Guidance Note 14 is To assist listed entities and their advisers to understand the operations of the ASX Market Announcements Platform (MAP) and the ASX MarketAnnouncements Office (MAO).
14. Guidelines on the contents of announcements
An announcement for release to the market must be accurate, complete and not misleading.
........
MAP should only be used to publish information that is appropriately given to ASX under the Listing Rules or the Corporations Act for publication to the market. It should not be used as a guise to publish material that is really promotional, political or tendentious in nature.
..........
ASX may refuse to accept or publish an announcement from a listed entity that does not meet the standards described above or may require the entity to lodge a corrective announcement.
https://www.asx.com.au/documents/rules/gn14_asx_market_announcements_platform.pdf
- Forums
- ASX - By Stock
- BRN
- Ann: BrainChip Evaluates Redomiciling to US
BRN
brainchip holdings ltd
Add to My Watchlist
0.00%
!
20.0¢

Ann: BrainChip Evaluates Redomiciling to US, page-379
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $405.0M |
Open | High | Low | Value | Volume |
20.5¢ | 21.0¢ | 20.0¢ | $1.544M | 7.615M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 61852 | 20.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.5¢ | 217258 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 32537 | 0.200 |
25 | 968327 | 0.195 |
38 | 1574473 | 0.190 |
40 | 1943108 | 0.185 |
65 | 1281316 | 0.180 |
Price($) | Vol. | No. |
---|---|---|
0.205 | 179258 | 6 |
0.210 | 1653584 | 26 |
0.215 | 846002 | 16 |
0.220 | 1267378 | 34 |
0.225 | 840448 | 18 |
Last trade - 16.20pm 27/06/2025 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online